VAV1 and breast carcinoma: The study group consisted of 126 patients with primary unilateral breast carcinoma (T1/T2), with no evidence of nodal involvement and distant metastases (Table 1), in which both Vav1 and phosphorylated Akt were evaluated by immunohistochemistry on TMAs.